Literature DB >> 23639529

Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery.

Zhuxian Zhou1, Xinpeng Ma, Erlei Jin, Jianbin Tang, Meihua Sui, Youqing Shen, Edward A Van Kirk, William J Murdoch, Maciej Radosz.   

Abstract

Elongated micelles have many desirable characteristics for cancer-drug delivery, but they are difficult to obtain since amphiphilic polymers form such nanostructures only within narrow composition ranges depending on their own structures. Herein, we demonstrated a facile fabrication of different nanostructures via drug content-controlled self-assembly of amphiphilic linear-dendritic drug conjugates - using the number of the conjugated hydrophobic drug molecule camptothecin (CPT) to tailor the hydrophobicity of amphiphilic PEG-block-dendritic polylysine-CPT (PEG-xCPT) conjugates and thereby control their self-assembled nanostructures - nanospheres or nanorods of different diameters and lengths. The shape and size of the nanostructures were found to strongly affect their in vitro and in vivo properties, particularly the blood clearance kinetics, biodistribution and tumor targeting. The nanorods with medium lengths (<500 nm) had a much longer blood circulation and faster cellular uptake than the nanospheres or long nanorods. Thus, polymeric nanorods with proper lengths may be ideal nanocarriers capable of uniting the opposite requirements in cancer-drug delivery.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23639529     DOI: 10.1016/j.biomaterials.2013.04.012

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  18 in total

Review 1.  One-component nanomedicine.

Authors:  Hao Su; Jin Mo Koo; Honggang Cui
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

2.  Investigation of the self-assembly of CS and PCL copolymers with different molecular weights in water solution by coarse-grained molecular dynamics simulation.

Authors:  Chun-Yi Chang; Shin-Pon Ju; Li-Fang Wang; Chien-Chia Chen; Ying-Chen Chuang; Hong-Lin Wu; Hsin-Tsung Chen
Journal:  J Mol Model       Date:  2017-04-03       Impact factor: 1.810

Review 3.  Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue.

Authors:  Muhammad Usman Munir
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

Review 4.  Hydroxyethyl starch and its derivatives as nanocarriers for delivery of diagnostic and therapeutic agents towards cancers.

Authors:  Ronghua Tan; Ying Wan; Xiangliang Yang
Journal:  Biomater Transl       Date:  2020-12-28

Review 5.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

Review 6.  Anticancer nanoparticulate polymer-drug conjugate.

Authors:  Quanyou Feng; Rong Tong
Journal:  Bioeng Transl Med       Date:  2016-10-28

7.  Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel.

Authors:  Xiaoyu Pei; Feifei Luo; Jun Zhang; Wulian Chen; Chen Jiang; Jie Liu
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

Review 8.  Dendritic Polymers for Theranostics.

Authors:  Yuan Ma; Quanbing Mou; Dali Wang; Xinyuan Zhu; Deyue Yan
Journal:  Theranostics       Date:  2016-04-27       Impact factor: 11.556

9.  Self-defensive nano-assemblies from camptothecin-based antitumor drugs.

Authors:  Si-Yong Qin; Meng-Yun Peng; Lei Rong; Bin Li; Shi-Bo Wang; Si-Xue Cheng; Ren-Xi Zhuo; Xian-Zheng Zhang
Journal:  Regen Biomater       Date:  2015-08-10

Review 10.  Design considerations for nanotherapeutics in oncology.

Authors:  Triantafyllos Stylianopoulos; Rakesh K Jain
Journal:  Nanomedicine       Date:  2015-08-15       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.